Katharine Harding

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 511 citations · Full text

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

Katharine Harding, Owain Williams, Mark Willis et al. · JAMA Neurology · 2019 · 342 citations · Full text

Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy

Orla Tuohy, Lisa Costelloe, Grant Hill-Cawthorne et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 238 citations · Full text

<scp>COVID</scp> ‐19 Vaccine Response in People with Multiple Sclerosis

Emma Tallantyre, Nicola Vickaryous, Valerie Anderson et al. · Annals of Neurology · 2021 · 150 citations · Full text

Demographic and clinical factors associated with changes in employment in multiple sclerosis

Phil Moore, Katharine Harding, Hannah Clarkson et al. · Multiple Sclerosis Journal · 2013 · 138 citations